1-3 of 3
Ted P. Szatrowski
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I/II Study of the Oral mTOR Inhibitor RAD001 in Patients with Advanced Hematologic Malignancies.

Karen W.L. Yee, MD, William Wierda, MD, Susan O’Brien, MD, Deborah Thomas, MD, Razelle Kurzrock, MD, Luis E. Fayad, MD, Fredrick B. Hagemeister, MD, Jorge Cortes, MD, Judith Prestifilippo, MD, Ted P. Szatrowski, MD, Hagop M. Kantarjian, MD, Francis J. Giles, MD
Journal: Blood
Blood (2004) 104 (11): 4818.
https://doi.org/10.1182/blood.V104.11.4818.4818
Published: 2004
Journal Articles

Prospective Karyotype Analysis in Adult Acute Lymphoblastic Leukemia: The Cancer and Leukemia Group B Experience

Meir Wetzler, Richard K. Dodge, Krzysztof Mrózek, Andrew J. Carroll, Ramana Tantravahi, AnneMarie W. Block, Mark J. Pettenati, Michelle M. Le Beau, Stanley R. Frankel, Carleton C. Stewart, Ted P. Szatrowski, Charles A. Schiffer, Richard A. Larson, Clara D. Bloomfield
Journal: Blood
Blood (1999) 93 (11): 3983–3993.
https://doi.org/10.1182/blood.V93.11.3983
Published: 1999
Journal Articles

Value of Immunophenotype in Intensively Treated Adult Acute Lymphoblastic Leukemia: Cancer and Leukemia Group B Study 8364

Myron S. Czuczman, Richard K. Dodge, Carleton C. Stewart, Stanley R. Frankel, Frederick R. Davey, Bayard L. Powell, Ted P. Szatrowski, Charles A. Schiffer, Richard A. Larson, Clara D. Bloomfield
Journal: Blood
Blood (1999) 93 (11): 3931–3939.
https://doi.org/10.1182/blood.V93.11.3931
Published: 1999